Sign in
4

Changes in Ownership

ATOSSA THERAPEUTICS, INC. Filed Acc 0001437749-22-004668

Options or other derivatives

  • CFO, Gen Counsel and Secretary acquired 746,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Guse Kyle CFO, Gen Counsel and Secretary 2022-02-24 Grant or award · Stock Option (right to buy) +746,667 746,667 D
Loading xslF345X03/rdgdoc.xml…